Scholarlink

<p>Tumor lysis syndrome (TLS) is a life-threatening condition due to the rapid release of tumor cell contents into the bloodstream usually induced by cytotoxic therapy. It is characterized by the rapid onset of severe metabolic derangements such as hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. If not promptly recognized and treated, TLS can lead to serious clinical complications including acute kidney injury (AKI), cardiac arrhythmias, seizures, hypotension, and death. In particular, the occurrence of AKI could cause a delay in the administration of chemotherapy, thus compromising the efficacy of the treatment and contributing to worsening patient’s prognosis. In this condition, a multidisciplinary approach appears crucial to implement strategies aimed at timely managing TLS and preventing AKI to improve main patient outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Management of acute kidney injury in tumor lysis syndrome: a narrative review

  • 期刊论文

  • 发表日期：

    2025年7月19日

查看全文
  • Laura Zeppilli,
  • Santo Morabito,
  • Antonietta Gigante,
  • Valentina Pistolesi

摘要

Tumor lysis syndrome (TLS) is a life-threatening condition due to the rapid release of tumor cell contents into the bloodstream usually induced by cytotoxic therapy. It is characterized by the rapid onset of severe metabolic derangements such as hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. If not promptly recognized and treated, TLS can lead to serious clinical complications including acute kidney injury (AKI), cardiac arrhythmias, seizures, hypotension, and death. In particular, the occurrence of AKI could cause a delay in the administration of chemotherapy, thus compromising the efficacy of the treatment and contributing to worsening patient’s prognosis. In this condition, a multidisciplinary approach appears crucial to implement strategies aimed at timely managing TLS and preventing AKI to improve main patient outcomes.